Home > Education : Prostate Cancer Outcomes
Prostate Cancer Programs: Developing Tools and Measuring Effectiveness in the Community Setting
Although a variety of decision aids (tools) have been developed for early-stage prostate disease, the impact of decision aids on patients with metastatic or advanced prostate cancer remains unclear. The goal of this project is to develop outcomes measures and tools for this patient population and to measure their effectiveness in improving patient outcomes and satisfaction.
Resources
Here's an annotated bibliography of treatment, quality measures, patient satisfaction, decision aids, decision-making, and more.
Objectives
- To develop criteria for measuring outcomes that indicate success in treating patients with metastatic or advanced prostate cancer. (Criteria must be easily recordable, standardized across all participating programs, simple to maintain on a regular basis, and include both clinical and non-clinical data.)
- To develop practical tools to assist programs in both measuring specific outcomes and improving care for patients with metastatic or advanced prostate cancer. (Examples of possible tools include model patient survey instruments, treatment planning guides, organizational flowcharts, and patient flowcharts.)
- To apply these criteria and tools at cancer programs actively involved in treating patients with metastatic or advanced prostate cancer.
- To determine and measure which criteria and tools affect outcomes and increase success in treating patients with metastatic or advanced prostate cancer.
- To share effective tools and report the study results in a formal educational venue available to all providers.
Project Components
In Phase I of the project, an expert ACCC advisory panel, in collaboration with a leading healthcare consulting company, will develop the criteria for measuring outcomes and the tools to assist programs in measuring specific outcomes and improving care. The advisory panel will include providers from programs already identified as having effective practices in community-based prostate cancer care.
In Phase II, 10 cancer programs from across the country will participate in the project for a period of about 8 to 12 months. After a baseline is established, participants will implement the tools, and changes in results will be measured against the outcomes criteria.
ACCC's MyNetwork
Facebook
LinkedIn
Twitter
ACCC Vision Channel